SSRIs are the most common antidepressants used during pregnancy

  • Molenaar NM & al.
  • J Affect Disord
  • 9 Dec 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Selective serotonin reuptake inhibitors (SSRIs) are the most commonly used antidepressants during pregnancy around the world, with an international prevalence of 3.0%.
  • The highest prevalence was reported in North America at 5.46% and the lowest in Australasia at 1.35%.

Why this matters

  • The prevalence of antidepressant use during pregnancy has increased over time in countries included in the meta-analysis, with the largest increase reported between 2001 and 2013.

Study design

  • A meta-analysis of 40 studies collected after search of Embase, Medline Ovid, Web of Science, Cochrane Central, and Google Scholar during 2019.
  • Funding: None.

Key results

  • The prevalence of antidepressants for SSRIs during pregnancy was 2.33% (95% CI, 2.32%-2.34%) using a fixed-effects model and 3.01% (95% CI, 2.29%-3.74%; P=.10) using a random-effects model.
  • Prevalence rates of SSRIs were:
    • Highest in North America: 5.46% (95% CI, 4.83%-6.10%); and
    • Lowest in Australasia: 1.35% (95% CI, 0.20%-2.50%).
  • Among all SSRIs, highest prevalence rates were seen for (P<.01 style="list-style-type:circle;">
  • Sertraline (1.10%);
  • Citalopram (0.77%); and
  • Fluoxetine (0.76%).

Limitations

  • Heterogeneity among studies.

Coauthored with Chitra Ravi, MPharm